1. Introduction {#sec1}
===============

Thromboxane A~2~ (TxA~2~) is produced enzymatically from arachidonic acid through the action of several enzymes including cyclooxygenase (COX) and thromboxane synthase in response to tissue injury, promoting hemostasis, vasoconstriction, and wound healing.^[@ref1]−[@ref3]^ However, these necessary features for survival can also cause death to those susceptible to or suffering from cardiovascular disease (CVD).^[@ref4]−[@ref9]^ Current first-line therapy involves the use of nonsteroidal anti-inflammatory drugs (NSAIDs) which block \>95% of COX1 activity and therefore TxA~2~ production.^[@ref10]^ However, the treatment suffers from side effects associated with shutting down the whole prostanoid cascade and with resistance in some patient groups.^[@ref11]^

The study of TxA~2~ has been limited by its high instability (*t*~1/2~ = 32 s, pH = 7.4)^[@ref1]^ and so a number of more stable analogues have been prepared in which one or both oxygens of the strained acetal have been replaced by carbon,^[@ref12]^ sulfur,^[@ref13]^ or a less strained bicyclic structure (e.g., U46619, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref14],[@ref15]^ A different strategy is to retain the strained acetal but reduce the rate of hydrolysis by incorporating either bromine^[@ref16]^ or, more importantly, fluorine^[@ref17]−[@ref20]^ atoms at the C-10 position ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Although the synthesis^[@ref21],[@ref22]^ of monofluorinated F-TxA~2~**1** has been attempted,^[@ref23]^ only the difluoro analogue **2** has succumbed to total synthesis,^[@ref17]^ which showed similar potency in platelet aggregation to the parent compound.^[@ref20]^ The stability of **2** has only been investigated using a model compound (**3**), which, as expected, showed much higher stability than TxA~2~ (*t*~1/2~ \> 30 days, pH = 7.4).^[@ref20]^ We were interested in targeting F-TxA~2~**1** since the number of fluorine atoms can have a significant impact on function. For example, in a comparative study of the CHF- and CF~2~- phosphonate analogues of *sn*-glycerol-3-phosphate, O'Hagan found that the monofluorinated was better than the difluorinated substrate for the dehydrogenase enzyme.^[@ref24]−[@ref26]^ We now report the first synthesis of F-TxA~2~**1** and compare its stability and biological activity with that of F~2~-TxA~2~**2**.

![Thromboxane A~2~ and its analogues.](oc0c00310_0001){#fig1}

2. Results and Discussion {#sec2}
=========================

Our retrosynthetic analysis of F-TxA~2~ is shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. We envisioned forming the strained acetal by an intramolecular cyclization and introducing the upper side chain by a Wittig reaction on the corresponding fluorinated lactol. Lactone **6** could be obtained by fluorination of the enolate of lactone **7**, which itself could be synthesized by Baeyer--Villiger oxidation of ketone **8**. Ketone **8** could then be obtained from conjugate addition of the lower side chain **9** to our key enal intermediate **10** followed by ozonolysis. At the outset, the main challenges presented in the synthesis were formation of the strained acetal and fluorination of the enolate bearing a potential leaving group at the β-position.

![Retrosynthesis of Fluorinated Thromboxanes from Bicyclic Enal](oc0c00310_0004){#sch1}

Synthesis of Fluorinated Thromboxane A~2~ {#sec2.1}
-----------------------------------------

Our synthesis began from PMB-acetal **12**, available in 3 steps in high er using our established proline-catalyzed aldol dimerization of succinaldehyde ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref27],[@ref28]^ Initially, we elected to carry through the major β-isomer of the acetal to simplify analysis. Conjugate addition of the mixed vinyl cuprate **13** followed by trapping with TMSCl and ozonolysis^[@ref27]^ gave ketone **14** which was converted into the key lactone intermediate **15** through a Baeyer--Villiger oxidation^[@ref29],[@ref30]^ (64% yield, over 3 steps).

![Synthesis of Key Lactone Precursor and Completion of the Synthesis of the Monofluorinated Thromboxane A~2~](oc0c00310_0005){#sch2}

With a scalable synthesis of lactone **15** in hand, we embarked on the fluorination reaction. Lactones bearing siloxy and benzyloxy groups in the β-position are particularly prone to elimination upon deprotonation and have to be trapped by reactive electrophiles at low temperature.^[@ref31]−[@ref35]^ Initial investigation showed that NFSI was a sufficiently reactive electrophile, and after optimization we found that the reaction proceeded with good selectivity (10:1 dr) and yield (51%) using 1.2 equiv KHMDS and 2.5 equiv NFSI in Et~2~O. Following PMB deprotection with DDQ, we explored the Wittig reaction with (4-carboxybutyl)triphenyl-phosphonium bromide (**18**), but this invariably led to intractable mixtures. We suspected that the lactone was interfering in this step and so converted lactone **16** into siloxyacetal. This time, following PMB deprotection, Wittig reaction using phosphonium salt **18** with *t*-BuOK surprisingly gave the corresponding epoxide in 67% yield.^[@ref36]^ To avoid epoxide formation, we screened alternative conditions and found that using LiHMDS with a ratio of hemiacetal (**17**):Wittig salt:LiHMDS of 1:4:8 at 0 °C gave the corresponding alkene in 82% yield as a separable 5:1 mixture of *Z*/*E* isomers after esterification with TMSCHN~2~. Selective desilylation of the TIPS group with TBAF/AcOH gave the required lactol **19** in 98% yield.^[@ref37]−[@ref41]^

To complete the synthesis of 10-F-TxA~2~, we required a method for the construction of the strained acetal. Owing to its known sensitivity and the low yields previously obtained for the construction of this motif, we decided to explore this key step on model substrate **23**. This was prepared from [d]{.smallcaps}-arabinal-derived glycal **22** by fluorination with selectfluor ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).^[@ref42]−[@ref44]^ Two methods for making the strained acetal had been reported previously, Still's Mitsunobu reaction^[@ref45],[@ref46]^ and Fried's displacement of the mesylate,^[@ref17]−[@ref20]^ but neither was successful on hemiacetal **23** as shown in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. These synthetic hurdles required us to find a new method to make the strained acetal. Shoda reported that treatment of unprotected glycopyranoses with 2-chloro-1,3-dimethylimidazolinium chloride (DMC) gave the corresponding 1,6-anhydro sugars directly.^[@ref47],[@ref48]^ This reagent was tested on hemiacetal **23**, but although we did not obtain the desired acetal **24** directly, we did isolate chloride **26** with complete chemoselectivity. The fortuitous formation of the (unstable) chloride presented another opportunity, since glycosyl chlorides can be activated by silver salts to promote their displacement.^[@ref49]^ Indeed, treatment with Ag~2~O promoted cyclization giving the acetal **24** in 40% yield, providing a novel solution to the synthesis of strained acetals.

![Formation of Strained Acetal on Model Hemi-acetal 23](oc0c00310_0006){#sch3}

Moving onto the real target, brief optimization of the chlorination/cyclization steps was again required but optimum conditions were quickly established. Treatment of hemiacetal **19** with 6 equiv of each of the chlorination reagent, DIPEA, and Ag~2~O gave the desired acetal **21** in 52% yield ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Finally, hydrolysis of **21** with 1.0 N NaOH in 50% 1,4-dioxane/water followed by deprotection with TBAF furnished F-TxA~2~**1** in 78% yield.

We also tried to prepare the other diastereoisomer 10α-F-TxA~2~ from the minor diastereomer formed in the fluorination of lactone **15**. While we were able to carry this diastereoisomer through to the corresponding diol (hydroxy hemiacetal, diastereomer of **19**), attempts to prepare the chloride and the subsequent cyclization were thwarted by competing elimination and hydrolysis.

By adapting this strategy, we were able to prepare F~2~-TxA~2~ (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c00310/suppl_file/oc0c00310_si_001.pdf)), so that its stability and biological activity could also be assessed. With both fluorinated TxA~2~ analogues in hand, we were then able to compare their stabilities with the parent TxA~2~ and study their biological activity.

Stability Studies of Fluorinated Thromboxane A~2~ and Model Compounds {#sec2.2}
---------------------------------------------------------------------

The hydrolytic stability of TxA~2~ at pH 7.4 (37 °C) was measured and found to have a *t*~1/2~ of 32 s.^[@ref1]^ Fried measured the stability of his F~2~-TxA~2~ model compound **3**, which is similar in structure to F~2~-TxA~2~, at pH 1.27 (22 °C) to have a *t*~1/2~ of 86 min. While this 10^8^ difference in rate constant is interesting to note, the difference in pH and temperature of these measurements renders a direct comparison of stability, and an assessment of the effect of fluorine, very difficult. Hence, we sought to compare the stability of TxA~2~ with its fluorinated analogues by measuring the kinetics of hydrolysis under the same conditions. Using ^19^F NMR to monitor the decay of the acetal moiety, we determined pseudo first-order rate constants for the hydrolysis of **1** and **2** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) under buffered conditions. At pH 7.4, we found that F-TxA~2~ (**1**) has a half-life of 20 days, which is 10^5^ more stable than TxA~2~. Interestingly, F~2~-TxA~2~ (**2**) was only 1 order of magnitude more stable at pH 7.4 with a half-life of over 40 weeks. We then measured hydrolysis rates of **1** and **2** at lower pHs ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), where, as expected, decreasing the pH decreased the stability. The rate of hydrolysis we measured for F~2~-TxA~2~ (**2**) at pH 1.25 (*t*~1/2~ = 64 min) was in good agreement with that of Fried's model compound **3** at pH 1.27 (*t*~1/2~ = 86 min).^[@ref20],[@ref50]^

###### Kinetics of Hydrolysis.[a](#t1fn1){ref-type="table-fn"}

![](oc0c00310_0008){#gr5}

  compound                               pH               *k*~1~′ (s^--1^)   *t*~1/2~
  -------------------------------------- ---------------- ------------------ ----------
  F-TxA~2~ (**1**)                       7.40             3.93 × 10^--7^     20 days
  2.42                                   8.93 × 10^--5^   2.2 h              
  F~2~-TxA~2~ (**2**)                    7.40             2.5 × 10^--8^      46 weeks
  2.42[b](#t1fn2){ref-type="table-fn"}   1.01 × 10^--6^   190 h              
  1.80                                   5.46 × 10^--5^   3.5 h              
  1.25                                   1.80 × 10^--4^   64 min             

Hydrolyses of **1** and **2** were measured under buffered conditions (50 mM), using ^19^F NMR to monitor the decay of the ketal. *k*~1~′ = pseudo first-order rate constants. *t*~1/2~ = half-life.

Average of two runs.

The marginal increase in stability of **2** compared to **1** at pH 7.4 was unexpected, as the increase in stability caused by inductive effects of the electronegative fluorine atoms is usually additive.^[@ref51],[@ref52]^ Thus, we speculated that there might be a strong stereoelectronic effect governing the stability of the strained acetal. Unfortunately, we were not able to prepare 10α-F-TxA~2~ to test this, so we compared the stability of the two diastereoisomers of model compound **24** (3α-**24** with 3β-**24**, [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Indeed, we measured a very substantial difference in hydrolysis rate between the isomers: 3β-**24** was ca. 200× more stable than 3α-**24**. The greater lability of 3α vs 3β-**24** presumably originates from having a better σ-donor (C--H vs C--F bond) aligned to the incipient oxocarbenium ion, as supported by DFT calculations on a model substrate ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}; see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c00310/suppl_file/oc0c00310_si_001.pdf) for further discussion). Our inability to make 10α-F-TxA~2~ could therefore be due to its greater instability. Furthermore, as **3a-24** exhibited a half-life of just 15 h at pH 7.4, it is likely that 10α-F-TxA~2~ would not have been suitable for biological studies (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c00310/suppl_file/oc0c00310_si_001.pdf) for full details). These studies therefore reveal that the stability derived from the stereoelectronic effect of an antiperiplanar fluorine is very significant compared to a syn-periplanar fluorine and provides a rationale for the nonadditive inductive effect of fluorine atoms on acetal hydrolysis.

![Investigations into Hydrolysis of Model Compound 24](oc0c00310_0007){#sch4}

Biological Studies {#sec2.3}
------------------

To evaluate the biological activity of the fluorinated thromboxanes **1** and **2**, concentration--response experiments were performed on human platelets, and platelet aggregation was recorded by light transmission aggregometer. The stable PGH~2~ analogue U46619 has been used widely as a standard of comparison for evaluating TxA~2~-like activity and so was included in this study.^[@ref53]−[@ref56]^ Concentration--response curves were fitted ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) and EC~50~ values were calculated ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The data show that F-TxA~2~ has similar activity as U46619 in inducing platelet aggregation but is almost 3-fold less potent than F~2~-TxA~2~. While F~2~-TxA~2~ was more potent, the *E*~Max~ was significantly lower than U46619 and F-TxA~2~, suggesting partial agonism at TxA~2~ receptors. As platelet amplification pathways such as ADP release and integrin α~IIb~β~3~ outside-in signaling can potentially mask a weaker agonist response in aggregation experiments, we were also interested to study a more direct functional readout of platelet activation: integrin α~IIb~β~3~ activation. Interestingly, we found that, in contrast to F-TxA~2~ and U46619, F~2~-TxA~2~ induced only weak integrin α~IIb~β~3~ activation ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Since both F-TxA~2~ and U46619 have similar activity in both aggregation and integrin α~IIb~β~3~ activation experiments and U46619 has comparative activity to TxA~2~,^[@ref23]^ our data strongly indicates that F-TxA~2~ is a closer mimic to TxA~2~ than F~2~-TxA~2~. Further biological and pharmacological studies are ongoing.

![TxA~2~-like properties of mono- and difluorinated TxA~2~ analogues on platelet aggregation. Aggregation of human platelet-rich-plasma induced by U46619, F-TxA~2~, and F~2~-TxA~2~ (average ± SEM, *n* = 3).](oc0c00310_0002){#fig2}

###### Concentration of TxA~2~ Analogues Which Produces 50% Of Maximal Aggregation

  compound          pEC~50~[a](#t2fn1){ref-type="table-fn"} ± SEM, *n* = 3   EC~50~[b](#t2fn2){ref-type="table-fn"} (μM), *n* = 3   *E*~Max~[c](#t2fn3){ref-type="table-fn"} (%) ± SEM, *n* = 3
  ----------------- -------------------------------------------------------- ------------------------------------------------------ -------------------------------------------------------------
  U46619            5.85 ± 0.06                                              1.4                                                    84.1 ± 2.7
  F-TxA~2~ (1)      5.80 ± 0.18                                              1.6                                                    77 ± 13.1
  F~2~-TxA~2~ (2)   6.30 ± 0.12                                              0.5                                                    69.3 ± 4.5

pEC~50~, the negative logarithm of EC~50~.

EC~50~, the concentration of agonist that produces 50% of maximum response.

E~Max~, the maximum aggregation in platelet-rich plasma.

![TxA~2~-like properties of mono and difluorinated TxA~2~ analogues on platelet integrin α~IIb~β~3~ activation. Washed platelets were stimulated with U46619, F-TxA~2~, and F~2~-TxA~2~ in the presence of 1 μM ADP for 15 min and integrin α~IIb~β~3~ activation was determined using FITC-PAC1 by FACS analysis. Data is expressed as a percentage of the maximal α-thrombin (0.5 U/mL) response (average ± SEM, *n* = 5).](oc0c00310_0003){#fig3}

3. Conclusions {#sec3}
==============

In summary, we have developed novel syntheses of chemically stable fluorinated thromboxanes, utilizing our key enal intermediate, which is readily available in high ee. The total synthesis of the F-TxA~2~ and F~2~-TxA~2~ were completed in 17 and 18 steps, respectively, from 2,5-dimethoxytetrahydrofuran. The scalable route enabled \>100 mg of advanced material (e.g., **21**) to be prepared for chemical and biological screening. In addition to overcoming some unexpected challenges associated with incorporating and carrying fluorine through a synthesis, we have also developed a new method for constructing the highly strained acetal. As expected, F-TxA~2~ does indeed possess markedly greater stability than TxA~2~, enabling it to be further studied in biological assays. Preliminary biological studies showed that F-TxA~2~ is the closest mimic to date of TxA~2~ having similar potency toward inducing platelet aggregation, and is considerably superior to F~2~-TxA~2~ in activating integrin α~IIb~β~3~.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acscentsci.0c00310](https://pubs.acs.org/doi/10.1021/acscentsci.0c00310?goto=supporting-info).Experimental procedures and characterization data for new compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c00310/suppl_file/oc0c00310_si_001.pdf))
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